Skip to content

ALFAMED

Active Private limited companyfounded 2006active for 20 yearsStrijdhoflaan 82, 2600 AntwerpKBO/BCE: BE 0880.358.736

Lifetime

20 annual accounts with figures on one time axis
peak of €701,329 in 2024
€688,201▼ 1.9%
peak of €483,391 in 2024
€476,182▼ 1.5%
peak of €791,990 in 2023
€450,636▼ 43.1%
€938,099▲ 41.4%
peak of 0 FTE in 2023
-not published
Board3 names since 2014
3 directors and 2 others
Documentsfilings and deeds
25-03-2026128 days before the deadline
2025micro format
Dividend €817,536Equity from €791,990 to €450,636Debts from €663,223 to €938,099

Key points

from the 2025 annual accounts

Equity

€450,636 ▼ 43.1%
791,9902024+476,182Profit-817,536Dividend450,6362025

ALFAMED paid out €817,536 in dividends. That is 172% of the 2025 profit.

Filings

20 annual accounts since 2006
AprilJune31 JulyOctober2010201520202025

Five of the last ten came late. The 2016 accounts came in latest, 31 days after the end of the period.

Position in the sector

€476,182

Higher net result than 95% of companies in human health. The sector median is €59,520, over 21,372 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,148 companies had the same profile as ALFAMED has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,148 companies, not a prediction for ALFAMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 12-06-2014
Director, since 12-06-2014
Director, since 12-06-2014
  • mandate holderdeed of 18-01-2023
  • mandate holderdeed of 18-01-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0880358736
2 managers resigning, 2 directors reappointed (manager) and (manager) resign · (director) and (director) reappointed · Partner: (mandate holder) · Gazette deed
(director) and (director) reappointed General meeting of 16-06-2020 · Gazette deed
New establishment in Antwerp Strijdhoflaan 70
All 34 events

Comparable companies

same main activity, similar in size and age
Company
ALFAMED Antwerp €1.4m €688,201 32.4% -
Dr. Marion Valkenburg Hove €1.6m €627,249 93.4% -
DR.DE LEENER HILDE-OOGARTS Lennik €1.4m €650,104 84.7% -
CABINET MEDICAL ANAPHYS Pepinster €1.4m €737,150 87.0% -
DOKTER OSMANAGAOGLU-DOKTER DURAN Ghent €1.6m €677,869 55.4% 1.2
DR. W. VERMOUT Ghent €1.5m €659,409 97.3% 0.4
Dokter Ellen Debrouwere Ingelmunster €1.3m €608,284 68.1% -

These companies have the same main activity as ALFAMED: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.3m and €1.6m, founded between 2004 and 2008.

Official details

Source: KBO
Status
Active since 30-03-2006Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment units
2.229.756.7172600 Antwerp, since 30-03-2006
2.248.798.5102600 Antwerp, since 01-01-2016
Financial year end
31 December
Peppol
Reachable since 26-11-2025
Company details

Annual accounts 2025

≈ €1.0mestimated
€1.4m▼ 4.6%
≈ 0.2 FTEestimated
Filing
Filed on 25-03-2026, 128 days before the end of the filing period
Financials

Insights on ALFAMED

ALFAMED files the micro format. That format states no turnover. The gross margin rose from €298,148 in 2006 to €688,201 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ALFAMED

What is the company number of ALFAMED?
The company number of ALFAMED is 0880.358.736. The VAT number is the same number with BE in front: BE 0880.358.736.
Where is ALFAMED based?
The registered office is at Strijdhoflaan 82, 2600 Antwerp.Company details
What does ALFAMED do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ALFAMED?
ALFAMED is a private limited company (BV).
When was ALFAMED founded?
ALFAMED was founded on 30-03-2006.
Is ALFAMED still active?
Yes, ALFAMED is an active enterprise in the KBO register.
What is the turnover of ALFAMED?
The turnover in financial year 2025 is about €1.0m. This figure is estimated from the gross margin of €688,201 and 31 comparable companies (NACE 86220). It probably lies between €920,000 and €1.4m.Financials
Is ALFAMED profitable?
In financial year 2025, ALFAMED made a profit of €476,182.
Where can I find the annual accounts of ALFAMED?
ALFAMED filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ALFAMED due?
ALFAMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.